Home /
Drugs / Human Papillomavirus 9-valent Vaccine, Recombinant
Human Papillomavirus 9-valent Vaccine, Recombinant
FDA Drug Profile — GARDASIL 9
Drug Details
- Generic Name
- Human Papillomavirus 9-valent Vaccine, Recombinant
- Brand Names
- GARDASIL 9
- Application Number
- BLA125508
- Sponsor
- Merck Sharp & Dohme LLC
- NDC Codes
- 5
- Dosage Forms
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN